Chrysalis DNX Transgenic Sciences

Chrysalis DNX Transgenic Sciences provides a full spectrum of transgenic animal capabilities, from transgenic mouse production to functional genomics and target validation. Since 1987, DNX has produced over 6000 unique transgenic mice and rats from over 1200 different genes. In addition to providing contract research capabilities to the biomedical research community, DNX's researchers have developed and characterized many animal models of human disease conditions. Chrysalis DNX Transgenic Sciences now provides gene cloning, gene modification by homologous recombination, model characterization and functional genomics programs to the pharmaceutical and biotechnology industry.

Activity:

- Contract Research

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: